New research by the Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with the GSK Vaccines Institute ...
AnteoTech (ASX:ADO) is classified by the Australian Securities Exchange as a materials company but part of its offering sits ...
A new mass spectrometry assay identifies patient-specific M-protein peptides in plasma without sequencing, showing generally ...
The cobas smart e immunoanalyser – the newest addition to Roche’s industry-leading cobas immunoassay systems portfolio – is ...
Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and ...
Edge Copper Corporation was pleased to announce the appointment of Chris Ballard as Vice President of Exploration, effective November 1, 2026. Mr. Ballard brings direct experience at the Company's 100 ...
MammoLink joins Mammogen’s KATELYN-ERIN trial, expanding community access to a prospective study evaluating blood-based RNA biology for breast ...
SEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the ...
CDK2/CycE1 is a cancer target linked to therapy resistance, and no inhibitor is reported to block formation of the complex specifically. Isogenica selected 192 unique VHHs against ...
A peer-reviewed study of 230 human clinical samples found that a CRISPR-assisted nanodroplet assay identified NTM species and ...
Morning Overview on MSN
Scientists want to catch mirror life before anyone builds it, using the trick behind 3D glasses
A proposed test for mirror life would read the handedness of living cells by the way they glow, using the same property of ...
Sword Bio and Alturas Analytics today announced a strategic collaboration designed to provide biotechnology and pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results